Glucagon-like peptide-1 (GLP-1) agonist medications are utilized to enhance metabolic health by improving insulin sensitivity, promoting weight loss, and offering cardiovascular (CV) risk-reduction benefits.

This comprehensive protocol outlines the use of GLP-1 medications alongside recommendations for nutritional shifts, supplement ingredients, labs, and tools to monitor and evaluate treatment. This approach helps to ensure a safe method to both initiating and de-escalating GLP-1 medications.

Reviewed by

Natacha Montpellier, ND

Medical Science Liaison

Dr. Natacha Montpellier is a registered naturopathic doctor in Ontario, Canada. She currently maintains a private clinical practice focused on hormonal and reproductive health. Dr. Natacha, ND, also serves as a Medical Science Liaison on Fullscript’s Medical Advisory team.

Disclaimer

This site is intended solely as an informational reference tool for practicing healthcare professionals. The content provided is not intended to be for medical diagnosis or treatment, is not a substitute for your professional judgment, and is not meant to provide you with medical or professional advice. You should evaluate and independently confirm the appropriateness of the content provided, and you should rely on your experience and judgment and other available resources when applying the provided content to an actual patient care situation. While content has been obtained from sources believed to be reliable, we cannot and do not guarantee the accuracy, validity, timeliness, or completeness of the content.